158 related articles for article (PubMed ID: 35429042)
1. Serpina3c deficiency induced necroptosis promotes non-alcoholic fatty liver disease through β-catenin/Foxo1/TLR4 signaling.
Qian LL; Ji JJ; Jiang Y; Guo JQ; Wu Y; Yang Z; Ma GS; Yao YY
FASEB J; 2022 May; 36(5):e22316. PubMed ID: 35429042
[TBL] [Abstract][Full Text] [Related]
2. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
[TBL] [Abstract][Full Text] [Related]
4. S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis.
Zhang L; Zhang Z; Li C; Zhu T; Gao J; Zhou H; Zheng Y; Chang Q; Wang M; Wu J; Ran L; Wu Y; Miao H; Zou X; Liang B
Cell Mol Gastroenterol Hepatol; 2021; 11(3):697-724. PubMed ID: 33075563
[TBL] [Abstract][Full Text] [Related]
5. Decrease in fat de novo synthesis and chemokine ligand expression in non-alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain-like pseudokinase.
Saeed WK; Jun DW; Jang K; Oh JH; Chae YJ; Lee JS; Koh DH; Kang HT
J Gastroenterol Hepatol; 2019 Dec; 34(12):2206-2218. PubMed ID: 31132314
[TBL] [Abstract][Full Text] [Related]
6. PTEN-mediated Akt/β-catenin/Foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury.
Kamo N; Ke B; Busuttil RW; Kupiec-Weglinski JW
Hepatology; 2013 Jan; 57(1):289-98. PubMed ID: 22807038
[TBL] [Abstract][Full Text] [Related]
7. p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1/FOXO1/IGF-1 signaling.
Kundu D; Kennedy L; Zhou T; Ekser B; Meadows V; Sybenga A; Kyritsi K; Chen L; Ceci L; Wu N; Wu C; Glaser S; Carpino G; Onori P; Gaudio E; Alpini G; Francis H
Hepatology; 2023 Jul; 78(1):243-257. PubMed ID: 36799449
[TBL] [Abstract][Full Text] [Related]
8. Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
Saeed WK; Jun DW; Jang K; Ahn SB; Oh JH; Chae YJ; Lee JS; Kang HT
World J Gastroenterol; 2018 Dec; 24(48):5477-5490. PubMed ID: 30622377
[TBL] [Abstract][Full Text] [Related]
9. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T
Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260
[TBL] [Abstract][Full Text] [Related]
10. Serpina3c regulates adipose differentiation via the Wnt/β-catenin-PPARγ pathway.
Guo J; Qian L; Ji J; Ji Z; Jiang Y; Wu Y; Yang Z; Ma G; Yao Y
Cell Signal; 2022 May; 93():110299. PubMed ID: 35263629
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
[TBL] [Abstract][Full Text] [Related]
12. Functional crosstalk between myeloid Foxo1-β-catenin axis and Hedgehog/Gli1 signaling in oxidative stress response.
Li C; Sheng M; Lin Y; Xu D; Tian Y; Zhan Y; Jiang L; Coito AJ; Busuttil RW; Farmer DG; Kupiec-Weglinski JW; Ke B
Cell Death Differ; 2021 May; 28(5):1705-1719. PubMed ID: 33288903
[TBL] [Abstract][Full Text] [Related]
13. Kindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice.
Gao H; Zhou L; Zhong Y; Ding Z; Lin S; Hou X; Zhou X; Shao J; Yang F; Zou X; Cao H; Xiao G
Nat Commun; 2022 Feb; 13(1):1025. PubMed ID: 35197460
[TBL] [Abstract][Full Text] [Related]
14. Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway.
Jiang B; Wang D; Hu Y; Li W; Liu F; Zhu X; Li X; Zhang H; Bai H; Yang Q; Yang X; Ben J; Chen Q
Mol Metab; 2022 May; 59():101462. PubMed ID: 35247611
[TBL] [Abstract][Full Text] [Related]
15. The role of MLKL in Hepatic Ischemia-Reperfusion Injury of Alcoholic Steatotic Livers.
Chen H; McKeen T; Chao X; Chen A; Deng F; Jaeschke H; Ding WX; Ni HM
Int J Biol Sci; 2022; 18(3):1096-1106. PubMed ID: 35173541
[TBL] [Abstract][Full Text] [Related]
16. MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis.
Wu X; Poulsen KL; Sanz-Garcia C; Huang E; McMullen MR; Roychowdhury S; Dasarathy S; Nagy LE
J Hepatol; 2020 Sep; 73(3):616-627. PubMed ID: 32220583
[TBL] [Abstract][Full Text] [Related]
17. FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease.
Zhang C; Chen F; Feng L; Shan Q; Zheng GH; Wang YJ; Lu J; Fan SH; Sun CH; Wu DM; Li MQ; Hu B; Wang QQ; Zhang ZF; Zheng YL
Mol Med; 2019 Jun; 25(1):29. PubMed ID: 31215394
[TBL] [Abstract][Full Text] [Related]
18. Excess fructose enhances oleatic cytotoxicity via reactive oxygen species production and causes necroptosis in hepatocytes.
Kanazawa J; Kakisaka K; Suzuki Y; Yonezawa T; Abe H; Wang T; Takikawa Y
J Nutr Biochem; 2022 Sep; 107():109052. PubMed ID: 35609854
[TBL] [Abstract][Full Text] [Related]
19. Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease.
Zhang J; Li S; Li J; Han C; Wang Z; Li C; Wang X; Liu Z; Wen J; Zheng L
Chin Med J (Engl); 2014; 127(21):3771-6. PubMed ID: 25382334
[TBL] [Abstract][Full Text] [Related]
20. Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis.
Lee S; Usman TO; Yamauchi J; Chhetri G; Wang X; Coudriet GM; Zhu C; Gao J; McConnell R; Krantz K; Rajasundaram D; Singh S; Piganelli J; Ostrowska A; Soto-Gutierrez A; Monga SP; Singhi AD; Muzumdar R; Tsung A; Dong HH
J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35700043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
